-
181
-
182
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores
Published 2021-06-01Get full text
Article -
183
Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease
Published 2017-03-01“…Gargi Ganguly,1 Sasanka Chakrabarti,2 Uttara Chatterjee,1 Luciano Saso3 1Department of Pathology, Institute of Post Graduate Medical Education and Research, Kolkata, 2Department of Biochemistry, ICARE Institute of Medical Sciences and Research, Haldia, West Bengal, India; 3Department of Physiology and Pharmacology “Vittorio Erspamer”, Sapienza University of Rome, Rome, Italy Abstract: Alzheimer’s disease and Parkinson’s disease are two common neurodegenerative diseases of the elderly people that have devastating effects in terms of morbidity and mortality. …”
Get full text
Article -
184
-
185
-
186
-
187
-
188
-
189
Studying the role of protein deamidation in neurodegenerative disease in proteome-wide scale
Published 2014Get full text
Final Year Project (FYP) -
190
-
191
-
192
-
193
Nanoencapsulated Curcumin: Enhanced Efficacy in Reversing Memory Loss in An Alzheimer Disease Model
Published 2024-01-01Get full text
Article -
194
Exosomal Dynamics and Brain Redox Imbalance: Implications in Alzheimer’s Disease Pathology and Diagnosis
Published 2024-03-01Get full text
Article -
195
-
196
Healthy Food Pyramid as Well as Physical and Mental Activity in the Prevention of Alzheimer’s Disease
Published 2022-04-01Get full text
Article -
197
-
198
Cerebrospinal fluid irisin correlates with amyloid‐β, BDNF, and cognition in Alzheimer's disease
Published 2020-01-01Get full text
Article -
199
Natural acetylcholinesterase inhibitors: A multi-targeted therapeutic potential in Alzheimer's disease
Published 2024-08-01Get full text
Article -
200
Allostery Inhibition of BACE1 by Psychotic and Meroterpenoid Drugs in Alzheimer’s Disease Therapy
Published 2022-07-01Get full text
Article